Walleye Capital LLC Trans Medics Group, Inc. Call Options Transaction History

Walleye Capital LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$72.62 - $150.62 $697,152 - $1.45 Million	9,600 New	9,600 $1.45 Million
Q3 2023 Nov 14, 2023	BUY	$53.47 - $96.07 $304,779 - $547,599	5,700 Added 300.0%	7,600 $416,000
Q2 2023 Aug 14, 2023	SELL	$66.23 - $88.73 $145,706 - $195,206	-2,200 Reduced 53.66%	1,900 $159,000
Q1 2023 May 15, 2023	BUY	$53.63 - $82.33 $21,452 - $32,932	400 Added 10.81%	4,100 $310,000
Q4 2022 Feb 14, 2023	BUY	$39.08 - $64.29 $66,436 - $109,293	1,700 Added 85.0%	3,700 $228,000
Q3 2022 Nov 14, 2022	BUY	$31.56 - $55.75 $63,120 - $111,500	2,000 New	2,000 $83,000

358

29.6M

399K

154K

Ticker TMDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,831,400
Market Cap $5B
Description
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.